Physician profile
Michael L Cross
NPI 1053484113
$4,505.69
in general payments reported to CMS, 2019-2025
10 companies · $99.49 in 2025
The $99.49 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $230 · 2020: $3,567 · 2021: $17.28 · 2022: $55.22 · 2023: $276 · 2024: $260 · 2025: $99.49.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $636.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $635.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,869.00 | 2020-2025 | Da Vinci Surgical System |
| Tela Bio, INC. | $213.49 | 2023-2024 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Angiodynamics, INC. | $105.00 | 2019 | |
| Ethicon US, LLC | $92.31 | 2019-2023 | Echelon Flex, Stratafix, Surgicel Nu-Knit |
| Covidien LP | $60.67 | 2019 | |
| Innovation Technologies INC | $52.56 | 2025 | Irrisept |
| Acell, INC. | $35.12 | 2019 | |
| Olympus America INC. | $32.50 | 2019-2020 | |
| Boston Scientific Corporation | $27.76 | 2023 | Wavewriter Alpha Prime 16 |
| Conmed Corporation | $17.28 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Cross listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.